| Literature DB >> 24227909 |
Abdulaziz Farooq1, Wade L Knez, Kelly Knez, Asma Al-Noaimi, Justin Grantham, Vidya Mohamed-Ali.
Abstract
UNLABELLED: Recent studies from the Gulf region suggest that compared to men, women have a greater risk of developing metabolic syndrome (MeS).Entities:
Mesh:
Substances:
Year: 2013 PMID: 24227909 PMCID: PMC3818915 DOI: 10.1155/2013/497324
Source DB: PubMed Journal: Mediators Inflamm ISSN: 0962-9351 Impact factor: 4.711
Anthropometry, body composition, lipid profile, iron indices, insulin sensitivity, and glucose handling in men and women.
| Variable | Men | Women |
|
|---|---|---|---|
| Age (years) | 32.6 ± 10.7 | 34.2 ± 10.1 | 0.55 |
| BMI (kg/m2) | 27.9 ± 5.9 | 28.3 ± 6.1 | 0.79 |
| Waist circumference (cm) | 95.4 ± 17.4 | 90.1 ± 11.3 | 0.19 |
| Body fat (%) | 32.7 ± 8.8 | 43.4 ± 6.3 | <0.01 |
| Systolic BP (mm Hg) | 127.6 ± 11.4 | 126.3 ± 16.8 | 0.73 |
| Diastolic BP (mm Hg) | 79.2 ± 9.9 | 77.8 ± 9.9 | 0.58 |
| Lipid profile | |||
| Total cholesterol | 5.1 ± 1.1 | 4.7 ± 0.7 | 0.19 |
| Triglycerides (mmol/L) | 1.2 ± 0.5 | 0.8 ± 0.4 | 0.01 |
| HDL (mmol/L) | 1.2 ± 0.2 | 1.4 ± 0.3 | 0.01 |
| LDL (mmol/L) | 3.2 ± 0.9 | 2.8 ± 0.7 | 0.06 |
| Iron indices | |||
| Haemoglobin (g/dL) | 14.8 ± 0.8 | 12.3 ± 0.7 | <0.01 |
| Serum iron ( | 15.2 ± 4.0 | 10.8 ± 5.7 | 0.05 |
| Serum ferritin ( | 105.9 ± 37.0 | 23 ± 20.1 | <0.01 |
| Iron-binding capacity | 56.9 ± 5.9 | 62.9 ± 9.6 | 0.10 |
| Urea nitrogen (mmol/L) | 5.0 ± 1.4 | 3.2 ± 0.7 | <0.01 |
| Creatinine (mmol/L) | 78.4 ± 17.3 | 55.8 ± 6.7 | <0.01 |
| Insulin sensitivity and glucose handling | |||
| Fasting glucose | 5.0 ± 0.5 | 5.0 ± 0.6 | 0.77 |
| Insulin ( | 4.23 (3.59–6.39) | 6.22 (3.82–10.7) | 0.12 |
| HOMA-IR | 1.07 (0.77–1.31) | 1.44 (0.82–2.24) | 0.19 |
| HbA1c (%) | 5.6 ± 0.3 | 5.6 ± 0.4 | 0.66 |
Data shown as mean ± SD or median (interquartile range).
BMI: body mass index; BP: blood pressure; HDL: high-density lipoprotein; LDL: low-density lipoprotein; HOMA-IR: homeostasis model of assessment-insulin resistance.
Regional fat characteristics measured by CT scan.
| Variable | Men | Women |
|
|---|---|---|---|
| Heart—total | 94.0 ± 68.0 | 155.0 ± 46.0 | <0.01 |
| Heart—intra | 19.0 ± 12.0 | 23.0 ± 7.0 | 0.04 |
| Liver—total | 93.9 ± 63.5 | 122.3 ± 47.3 | 0.09 |
| Liver—intra | 31.9 ± 20.6 | 29.9 ± 11.7 | 0.86 |
| Abdominal—total | 187.3 ± 113.3 | 247.1 ± 65.6 | 0.04 |
| Abdominal—omental | 50.7 ± 27.8 | 57.8 ± 22.3 | 0.18 |
| Abdominal—SC | 136.6 ± 89.3 | 176.8 ± 68.8 | 0.07 |
| Abdominal—SC, | 135.8 ± 86 | 140.5 ± 35.3 | 0.33 |
| Abdominal—SC, | 20.3 ± 19.4 | 42.4 ± 24.9 | 0.04 |
| Thigh—total | 52.2 ± 31.8 | 95.5 ± 32.1 | <0.01 |
| Thigh—intra | 3.2 ± 2.0 | 6.6 ± 3.6 | <0.01 |
| Thigh—muscle | 74.0 ± 11.2 | 54.1 ± 7.7 | <0.01 |
Data shown as mean ± SD.
SC: subcutaneous; super: superficial.
Correlation between metabolic markers, and serum adipokines and inflammatory markers in men and women.
| Metabolic marker | Adiponectin | CRP | RANTES | MCP-1 pg/mL | Leptin | IL-6 |
|---|---|---|---|---|---|---|
| Men | ||||||
| Total cholesterol (mmol/L) | 0.03 | 0.25 | −0.05 | 0.14 | 0.21 | 0.08 |
| Triglycerides (mmol/L) | 0.04 | 0.07 | −0.21 |
| 0.35 | 0.00 |
| HDL (mmol/L) | 0.23 | 0.04 | −0.06 | −0.08 | −0.09 | −0.01 |
| LDL (mmol/L) | −0.04 | 0.29 | −0.09 | 0.15 | 0.17 | 0.13 |
| Waist circumference (cm) | −0.07 |
| −0.06 | 0.25 |
| 0.76** |
| Systolic BP (mm Hg) | 0.00 |
| −0.21 | 0.10 |
|
|
| Diastolic BP (mm Hg) | 0.05 | 0.39 | −0.21 | 0.22 | 0.34 | 0.48* |
| Insulin ( | 0.05 | 0.46 | 0.12 | −0.19 |
| 0.35 |
| Fasting glucose (mmol) | −0.09 | 0.34 | 0.18 | 0.25 | 0.45 | 0.31 |
| HOMA-IR | 0.08 | 0.41 | 0.11 | −0.18 |
| 0.35 |
| VO2 Max (mL/kg/min) | 0.22 | −0.43* | −0.14 | −0.03 | −0.40 | −0.51* |
| Women | ||||||
| Total cholesterol (mmol/L) | −0.01 | 0.15 | 0.20 | 0.15 | 0.21 | 0.25 |
| Triglyceride (mmol/L) | − | 0.27 | 0.22 | −0.21 | 0.33 | 0.26 |
| HDL (mmol/L) | 0.28 | −0.06 | 0.01 | 0.11 | −0.01 | −0.25 |
| LDL (mmol/L) | −0.07 | 0.19 | 0.31 | 0.10 | 0.25 |
|
| Waist circumference (cm) | −0.10 | 0.01 | 0.14 | 0.25 | 0.07 | 0.53** |
| Systolic BP (mm Hg) | 0.32 | 0.14 | 0.24 | 0.21 | 0.08 | 0.17 |
| Diastolic BP (mm Hg) | −0.04 | 0.13 | 0.19 |
| 0.11 | 0.46* |
| Insulin ( | − | 0.27 | 0.28 | −0.44 | 0.50 | 0.23 |
| Fasting glucose (mmol) | −0.32 | 0.25 |
| −0.18 | 0.14 | 0.22 |
| HOMA-IR | −0.38 | 0.27 | 0.32 | −0.39 | 0.47 | 0.27 |
| VO2 Max (mL/kg/min) | 0.17 | −0.54** | 0.03 | −0.38 | −0.34 | −0.11 |
Data reported as Spearman correlation coefficients. Bold font indicates gender-specific correlations. *P < 0.05; **P < 0.01.
CRP: C-reactive protein; RANTES: regulated on activation, normal T cell expressed and secreted; MCP-1: monocyte chemotactic protein-1; IL-6: interleukin-6; HDL: high-density lipoprotein; LDL: low-density lipoprotein; BP: blood pressure; HOMA-IR: homeostasis model of assessment-insulin resistance; VO2 Max: maximal oxygen uptake.
Figure 1Serum levels of adipokines and inflammatory markers by gender. Data are expressed as Median (IQR) with different scales for each adipokines/cytokines. Only significant P values (Mann-Whitney P) are shown. M: Men; W: Women; CRP: C-reactive protein; RANTES: regulated on activation, normal T cell expressed and secreted; MCP-1: monocyte chemotactic protein-1; IL-6: interleukin-6.
Aerobic fitness and indices of strength.
| Variable | Men | Women |
|
|---|---|---|---|
| Peak HR (bpm) | 177.6 ± 17.5 | 177.0 ± 16.8 | 0.90 |
| Percentage of predicted maximal HR (%) | 94.9 ± 8.1 | 95.1 ± 9.0 | 0.95 |
| Bruce treadmill test duration (min) | 9.5 ± 1.8 | 6.8 ± 0.7 | <0.01 |
| VO2 Max (mL/kg/min) | 32.5 ± 7.1 | 26.0 ± 3.2 | <0.01 |
| Max handgrip (N) | 396.1 ± 88.8 | 256.3 ± 41.4 | <0.01 |
| Knee isometric peak (Nm) | 256.8 ± 58.7 | 155.3 ± 41.8 | <0.01 |
| Knee isokinetic 30 degree peak (Nm) | 194.2 ± 48.6 | 121.8 ± 28.3 | <0.01 |
| Knee isokinetic 120 degree peak (Nm) | 140.6 ± 32.2 | 82.9 ± 19.3 | <0.01 |
Data shown as mean ± SD.
HR: heart rate; VO2 Max: maximal oxygen uptake.
Figure 2Aerobic fitness in Qatari men and women in the current study, compared to the reported 50th percentile of aerobic fitness in a Caucasian population [27].